NAFLD and NASH inhibition test after PD, using pancelipase load test

NAFLD and NASH inhibition test after PD, using pancelipase load test - Fatty liver inhibition test after PD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009119

Enrollment

134

Registered

2012-10-15

Start date

2012-08-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver after PD

Interventions

Medication of pancre-lipase no treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: After pancreatoduodenectomy

Exclusion criteria

Exclusion criteria: 1) patient with HBs ana/or HCV positive 2)Patietns had fatt liver before PD 3) without fatty liver in histlogically 4) The infection patient who needs medical treatment 5)The patient of malabsorption syndrome 6)patients who had reoperation 7)patients who had rejected this srudy 8)patients had allergy of this drug 9)patients had pregnacy,

Design outcomes

Primary

Measure	Time frame
The rate of incidence of a fatty liver	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactMitsugi Shimoda

Dokkyo Medical University Second Department of Surgery

shimodamitsugi@hotmail.com0282-87-2158

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026